Park Avenue Securities’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
Park Avenue Securities's QGEN Position: Q2 2026 in Review
Park Avenue Securities reduced its Qiagen (QGEN) stake by 21% in Q2 2026, selling an estimated $73K and leaving 7,561 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.
Park Avenue Securities first reported a position in QGEN in Q3 2024 and has held it in 8 quarters since. The position peaked at $622K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.
- Park Avenue Securities held 7,561 shares of Qiagen worth $293K as of Q2 2026.
- Park Avenue Securities sold 1,965 Qiagen shares in Q2 2026, an estimated $73K.
- Qiagen made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1536 holding.
- Park Avenue Securities first reported a position in Qiagen in Q3 2024 and has held it in 8 quarters since.
- Park Avenue Securities's Qiagen position peaked at $622K in Q2 2025.
- 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.